Viatris Revenue and Competitors

VIATRIS™ is a new kind of global healthcare company formed in 2020 through the combination of Mylan and Upjohn, a legacy division of Pfizer. By integrating the strengths of these two companies, including our global workforce of approximately ~45,000, we aim to deliver increased access to affordable, quality medicines for patients worldwide, regardless of geography or circumstance. Our unique capabilities, commitment and vision position us to help meet the world’s evolving healthcare needs through access, leadership and partnership. As we work to help patients live healthier at every stage of life, we continue to advance responsible and sustainable operations, recognizing that our actions affect the stakeholders and communities we serve. Our global portfolio comprises more than 1,400 approved molecules across a wide range of therapeutic areas, spanning both non-communicable and infectious diseases, including globally recognized iconic brands, generic, complex generic and branded medicines, a growing portfolio of biosimilars, and a variety of over-the-counter consumer products. As the world’s healthcare needs evolve, our Global Healthcare Gateway™ offers partners ready access to expanded markets through an innovative global infrastructure that connects people around the world to high quality medicines and services they need. We encourage you to comment, ask questions and engage in conversation. By interacting with Viatris on social media, you agree to abide by our community guidelines: https://news.viatris.com/social-media-guidelines Viatris and its recruiting firms do not request banking or credit card information in connection with Viatris recruiting activities. Additionally, Viatris representatives do not request payment or personal bank information as part of our recruitment process. Viatris.com is the primary source of all company job postings and authorized third-party career websites.